Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population

被引：0
|
作者：
Mateusz Siedlinski
Dirkje S Postma
Jolanda MA Boer
Gerrit van der Steege
Jan P Schouten
Henriette A Smit
H Marike Boezen
机构：
[1] University Medical Center Groningen,Department of Epidemiology
[2] University of Groningen,Department of Pulmonology
[3] University Medical Center Groningen,Department of Medical Genetics
[4] University of Groningen,undefined
[5] National Institute for Public Health and the Environment,undefined
[6] University Medical Center Groningen,undefined
[7] University of Groningen,undefined
来源：
Respiratory Research | / 10卷
关键词：
Chronic Obstructive Pulmonary Disease; Complete Linkage Disequilibrium; Chronic Obstructive Pulmonary Disease Subject; Dutch Cohort; Pool Cohort;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Inhibition of SIRT1 promotes ultraviolet B induced cataract via downregulation of the KEAP1/NFE2L2 signaling pathway
    Wu, Feiying
    Xia, Xinyu
    Lei, Ting
    Du, Huiying
    Hua, Hui
    Liu, Wei
    Xu, Bin
    Yang, Tianyao
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2023, 245
  • [22] Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma
    Sheth, Siddharth
    Farquhar, Douglas R.
    Schrank, Travis P.
    Stepp, Wesley
    Mazul, Angela
    Hayward, Michele
    Lenze, Nicholas
    Little, Paul
    Jo, Heejoon
    Major, M. Ben
    Chera, Bhishamjit S.
    Zevallos, Jose P.
    Hayes, D. Neil
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2021, 6 (04): : 699 - 707
  • [23] Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer.
    Binkley, Michael S.
    Jeon, Young-Jun
    Nesselbush, Monica
    Moding, Everett J.
    Nabet, Barzin
    Almanza, Diego
    Yoo, Christopher
    Kurtz, David M.
    Owen, Susie Grant
    Backhus, Leah M.
    Berry, Mark F.
    Shrager, Joseph B.
    Ramchandran, Kavitha J.
    Padda, Sukhmani K.
    Das, Millie
    Neal, Joel W.
    Wakelee, Heather A.
    Alizadeh, Ash A.
    Loo, Billy W.
    Diehn, Maximilian
    CLINICAL CANCER RESEARCH, 2021, 27 (08)
  • [24] Mutations and expression of the NFE2L2/KEAP1/CUL3 pathway in Chinese patients with lung squamous cell carcinoma
    Zhang, Yongxing
    Fan, Hong
    Fang, Shuo
    Wang, Lin
    Chen, Li
    Jin, Yulin
    Jiang, Wei
    Lin, Zongwu
    Shi, Yu
    Zhan, Cheng
    Wang, Qun
    JOURNAL OF THORACIC DISEASE, 2016, 8 (07) : 1639 - +
  • [25] Germline variation in NFE2L2/CUL3/KEAP1 and risk of head and neck squamous cell carcinoma (HNSCC)
    Sheth, Siddharth
    Weissfeld, Joel L.
    Romkes, Marjorie
    Ferris, Robert L.
    Grandis, Jennifer R.
    Bauman, Julie E.
    Diergaarde, Brenda
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] KEAP1/NFE2L2 Transcriptomic Signature Predicts Survival in Advanced Stage NSCLC Patients Without Actionable Driver Mutations
    Scheffler, M.
    Dugan, M.
    Saleh, M. M.
    Koleczko, S.
    Bragelmann, J.
    Arolt, C.
    Nogova, L.
    Riedel, R.
    Michels, S.
    Eisert, A.
    Fischer, R.
    Scharpenseel, H.
    Weber, J. P.
    Scheel, A. H.
    Merkelbach-Bruse, S.
    Buttner, R.
    Lafleur, F.
    Wild, R.
    Catanzariti, L.
    Hillmer, A. M.
    Wolf, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S451 - S452
  • [27] Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2
    Yang, Xiaodong
    Li, Ming
    Chen, Zhencong
    Fan, Xiaobin
    Guo, Liang
    Jin, Bo
    Huang, Yiwei
    Wang, Qun
    Wu, Liang
    Zhan, Cheng
    JOURNAL OF CANCER, 2022, 13 (05): : 1512 - 1522
  • [28] NRF2 Pathway Signature Predicts KEAP1/NFE2L2 Mutations and Reveals Alternative Pathway-Activating Mutations in NSCLC
    Arolt, C.
    Dugan, M.
    Wild, R.
    Richartz, V.
    Holz, B.
    Scheel, A. H.
    Braegelmann, J.
    Merkelbach-Bruse, S.
    Wolf, J.
    Buettner, R.
    Lafleur, F.
    Scheffler, M.
    Catanzariti, L.
    Hillmer, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S411 - S412
  • [29] KEAP1/NFE2L2 as a prognostic biomarker on immunotherapy and correlation with immune infiltrates in non-small cell lung cancer (NSCLC).
    Zhu, Hongyuan
    Yu, Yunfang
    Zheng, Yating
    Xu, Bin
    Zheng, Shaopeng
    Zeng, Fanjun
    Xie, Wenzhuan
    Huang, Luyu
    Li, Fasheng
    Lin, Weihuan
    Liao, Guoqing
    Wu, Shaowei
    Liu, Xinyi
    Huang, Mengli
    Zhou, Haiyu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] NFE2L2 Polymorphisms Associated with Susceptibility to Tuberculosis in Chinese Tibetan Population
    He, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345